Societal Debates About Emerging Genetic Technologies: Toward a Science of Public Engagement
By Christopher D. Wirz,
Environmental Communication
| 09. 29. 2020
Gene editing is an inherently wicked problem
Societal debates about the applications of novel gene editing techniques like CRISPR in agriculture, wildlife, and humans have only rarely focused on questions that have correct or even factual answers. Of course, many discussions within the bench scientific community are focused on technical risks and benefits and the weighing of the latter against the former in the desire to develop climate- or pest-resistant crops (National Academies of Sciences, 2016) or therapies for devastating genetically-inherited diseases in humans (National Academy of Sciences & National Academy of Medicine, 2017).
While public debates are ideally informed by these scientific considerations, they are – by nature – much broader in scope. Gene drives developed to limit the spread of vector-borne illness carried by mosquitos, for instance, have raised concerns about the morality of “messing with nature” by editing the genome of living organisms for dominant traits, about creating imbalances in already fragile ecosystems, and about unintended and potentially irreversible long-term consequences for humans and nature (Brossard et al., 2019). At the same time, pesticides...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...